基本信息
views: 6
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
1. Key interests:
- Discovering new treatments for human disease using innovative approaches/technologies;
- Empowering large cross-disciplinary teams and organizations towards breakthrough scientific
and business opportunities;
- Following research on the origins of chirality and Life
2. Have directly contributed to 12 molecules that have progressed to human Phase I-III studies
in the areas of Oncology, CNS, Cardiovascular and Orphan Disorders;
3. Established track record in identifying, validating and implementing diverse technologies for
modern drug discovery;
4. Contributed to/authored >170 peer-reviewed scientific publications, >60 issued patents and patent applications, 7 book
chapters
- Discovering new treatments for human disease using innovative approaches/technologies;
- Empowering large cross-disciplinary teams and organizations towards breakthrough scientific
and business opportunities;
- Following research on the origins of chirality and Life
2. Have directly contributed to 12 molecules that have progressed to human Phase I-III studies
in the areas of Oncology, CNS, Cardiovascular and Orphan Disorders;
3. Established track record in identifying, validating and implementing diverse technologies for
modern drug discovery;
4. Contributed to/authored >170 peer-reviewed scientific publications, >60 issued patents and patent applications, 7 book
chapters
Research Interests
Papers共 47 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Load More
Author Statistics
#Papers: 47
#Citation: 1767
H-Index: 18
G-Index: 18
Sociability: 5
Diversity: 3
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn